Breast Cancer Meeting Highlights - Page 2 - HER2 Support Group Forums

		HER2 Support Group Forums
Breast Cancer Meeting Highlights

Breast Cancer Meeting Highlights News fro recent ASCO and San Antonio Meetings

Page 2 of 14

Last »

Threads in Forum : Breast Cancer Meeting Highlights

Forum Tools

Search this Forum

Rating Thread / Thread Starter	Last Post	Replies	Views
Her2 Posters Utilizing VeraTag Assays to be presented at SABCS Hopeful	12-12-2007 02:51 PM by Hopeful	0	2,179
BC patients w/1-3 positive nodes and low risk 70-gene profile have excellent survival Hopeful	12-17-2007 08:23 AM by Hopeful	0	1,422
Her2 Recurrence Rates pre-Herceptin Hopeful	12-16-2007 02:40 PM by Andrea Barnett Budin	9	2,784
Comparison of joint problems as reported by patients in a randomised adjuvant trial Hopeful	12-14-2007 02:43 PM by Hopeful	0	1,754
Impact of ERBB2 on prognosis and microarray data Hopeful	12-14-2007 02:45 PM by Hopeful	0	1,765
The clinical significance of polysomy 17 in the HER2+ N9831 intergroup adjuvant trast Hopeful	12-14-2007 02:48 PM by Hopeful	0	1,714
Mechanism of action of herceptin killing of HER-2+ breast cancer cells under in vitro Hopeful	12-14-2007 02:49 PM by Hopeful	0	1,766
AI's in early breast cancer toxicity and adherence Hopeful	12-14-2007 03:14 PM by Hopeful	0	2,084
Change in annual recurrence rates over the last 10 years - NORA study Hopeful	12-14-2007 03:36 PM by Hopeful	0	2,047
Confirmatory Tissue Biopsy for BC mets strongly recommended Hopeful	12-17-2007 08:25 AM by Hopeful	0	1,343
Multidisciplinary management of menopause symptoms after breast cancer Hopeful	12-17-2007 08:27 AM by Hopeful	0	1,255
For R.B - Her2 and fatty acid synthase in bc cells Hopeful	12-17-2007 08:29 AM by Hopeful	0	1,422
San Antonio Abstracts on line Early Hopeful	12-02-2008 09:42 AM by Hopeful	0	1,260
Determination of HER2 amplification - when should chromosome 17 also be determined Hopeful	12-14-2008 05:55 PM by Becky	2	2,087
BC patients unknowingly dosing themselves with estrogen by using topical moisturizers Hopeful	12-28-2008 01:28 PM by Rich66	9	2,845
A novel breast tissue feature strongly associated with risk of breast cancer Hopeful	12-10-2008 07:30 AM by Hopeful	0	1,858
HER-2 expression on circulating tumor cells in metastatic breast cancer Hopeful	12-10-2008 07:31 AM by Hopeful	0	1,591
Behaviour and metastatic potential of Her2+ and Her2-(CETC) during adjuvant therapy Hopeful	12-10-2008 07:34 AM by Hopeful	0	1,504
Metastatic potential of Her2+ and Her2- CETC released during primary systemic chemo Hopeful	12-11-2008 07:36 AM by Hopeful	0	1,553
Is metabolic syndrome the link between obesity and postmenopausal breast cancer? Hopeful	12-11-2008 07:38 AM by Hopeful	0	1,660
Promoter hypermethylation is an early event in breast carcinogenesis Hopeful	12-11-2008 07:40 AM by Hopeful	0	1,595
The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathologica Hopeful	12-11-2008 07:44 AM by Hopeful	0	1,475
Remarkable complete pathologic response rate in Her2+ stage II/III pts in phase II tr Hopeful	12-11-2008 07:47 AM by Hopeful	0	1,798
HER-2/neu expression/amplification is not stable during tumor progression Hopeful	12-12-2008 07:47 AM by Hopeful	0	1,652
PR receptor levels are associated with time to AI treatment failure Hopeful	12-12-2008 07:49 AM by Hopeful	0	1,808
HER2 amplification does not alter outcome in small (1 cm) tumors Hopeful	12-12-2008 07:50 AM by Hopeful	0	1,689
HER2 amplification predicts breast cancer recurrence but not overall survival Hopeful	02-03-2009 09:30 PM by gdpawel	3	2,675
Low penetrance breast cancer predisposition SNPs are site specific Hopeful	12-12-2008 07:52 AM by Hopeful	0	2,149
Pooled cardiac safety analysis of patients with HER2+ MBC receiving trastuzumab Hopeful	12-12-2008 07:54 AM by Hopeful	0	1,749
Chronobiological rhythms of cytokines level of breast cancer Hopeful	03-19-2009 07:00 AM by Hopeful	0	1,858
Presence of an in-situ component is associated with reduced biological aggressiveness Hopeful	03-18-2009 06:17 AM by Hopeful	0	1,697
The coamplification pattern of HER2/NEU amplicon and its clinical significance Hopeful	03-18-2009 06:18 AM by Hopeful	0	1,580
Tumor size vs Her2 amplification in post-meno, ER+ tamoxifen tx pts Hopeful	03-18-2009 06:22 AM by Hopeful	0	1,787
CYP2D6 pharmacogenetics stratifies tamoxifen treatment outcome Hopeful	03-18-2009 06:23 AM by Hopeful	0	1,602
The timing of recurrence after the surgery of breast cancer Hopeful	03-18-2009 06:24 AM by Hopeful	0	1,929
Is there a promotion of metastasis by autologeous breast reconstruction in patients? Hopeful	03-18-2009 06:25 AM by Hopeful	0	1,783
Soreness and sensitivity to sun exposure 10 to 16 years after breast cancer radiother Hopeful	03-19-2009 06:52 AM by Hopeful	0	1,797
Radiofrequency ablation of early breast cancer followed by delayed surgical resection Hopeful	03-19-2009 06:53 AM by Hopeful	0	1,649
Primary endocrine therapy versus chemo in postmen pts w/ ER+ bc: 5 yr results Hopeful	03-19-2009 07:02 AM by Hopeful	0	1,804
Testosterone protection: Salivary hormone levels in newly diagnosed breast cancer pts Hopeful	03-19-2009 07:04 AM by Hopeful	0	1,896
Combined ER and HER-targeted therapy in breast cancer treatment Hopeful	03-21-2009 10:23 PM by Jackie07	1	2,064
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen Hopeful	05-19-2009 06:32 AM by Hopeful	0	1,630
Treatment of node-negative infra-centimetric HER2+ invasive breast carcinomas Hopeful	05-19-2009 06:33 AM by Hopeful	0	1,540
PIK3CA gene expression signature and prognosis within the luminal-B ER+ bc Hopeful	05-19-2009 06:36 AM by Hopeful	0	1,757
Expression profile of CTC and corresponding tumors in primary breast cancer patients Hopeful	05-19-2009 06:38 AM by Hopeful	0	1,769
trastuzumab-related cardiac dysfunction in the HERA Trial with 3.6 years follow- up Hopeful	05-19-2009 06:40 AM by Hopeful	0	1,786
trial of acupuncture for the management of AI associated joint symptoms Hopeful	05-19-2009 06:41 AM by Hopeful	0	1,612
Association between HER2/neu overexpression and calcifications in breast cancer Hopeful	05-20-2009 06:23 AM by Hopeful	0	1,620
Evaluation of Adjuvant! Online to predict the effect of optimal endocrine therapy Hopeful	05-20-2009 06:26 AM by Hopeful	0	2,160
Risk factors associated with trastuzumab-associated cardiac toxicity Hopeful	05-20-2009 06:28 AM by Hopeful	0	1,766
HER-2/neu in tissue and serum at time of primary diagnosis of breast cancer Hopeful	05-20-2009 06:30 AM by Hopeful	0	1,644
Long-term follow-up and factors of survival of HER-2 positive breast cancer patients Hopeful	05-20-2009 06:31 AM by Hopeful	0	1,738
Response to neoadjuvant chemotherapy and outcome based on breast cancer subtype Hopeful	05-20-2009 08:24 AM by bejuce	1	1,976
Trastuzumab cardiotoxicity: FDA review Hopeful	05-21-2009 06:44 AM by Hopeful	0	1,751
Sensitivity to endocrine therapy of PR+/ER- patients and ER+/PR- patients with HER2+ Hopeful	05-21-2009 06:46 AM by Hopeful	0	1,729
Weight gain after adjuvant TAC (docetaxel, doxorubicin, and cyclophosphamide) chemo Hopeful	05-21-2009 06:50 AM by Hopeful	0	2,075
Surgery vs primary endocrine therapy for elderly women Hopeful	05-21-2009 06:51 AM by Hopeful	0	1,654
Off-label drug use in women with breast cancer Hopeful	05-21-2009 06:59 AM by Hopeful	0	1,767
Pertuzumab monotherapy following trastuzumab-based treatment Hopeful	05-28-2009 12:39 AM by Rich66	1	1,266
Complications associated with erythropoietin stimulating agents in mbc patients Hopeful	05-22-2009 06:41 AM by Hopeful	0	1,458
Risk and cost of anthracycline-induced cardiotoxicity among breast cancer patients in Hopeful	05-22-2009 06:44 AM by Hopeful	0	1,288
Characteristics of subsequent breast cancers in patients with benign breast disease Hopeful	06-01-2009 07:34 AM by Hopeful	0	1,094
What is the evidence for rechallenging with anthracyclines or taxanes in MBC? Hopeful	06-01-2009 07:39 AM by Hopeful	0	1,068
Differential timing and patterns of recurrence among breast cancer subtypes Hopeful	06-01-2009 07:40 AM by Hopeful	0	1,031
Impressive survival data with semimetronomic oral chemo Hopeful	06-02-2009 07:06 AM by Hopeful	0	952
Cardiac safety of the lapatinib/letrozole combination Hopeful	06-02-2009 07:08 AM by Hopeful	0	1,144
Concordant HER2 status between malignant CSF cells and primary breast carcinoma tissu Hopeful	06-02-2009 07:10 AM by Hopeful	0	1,072
Multifactorial CNS relapse susceptibility in HER2-positive breast cancer patients Hopeful	06-02-2009 07:12 AM by Hopeful	0	1,005
CA 125 in the early detection of metastatic breast cancer Hopeful	06-02-2009 07:15 AM by Hopeful	0	814
Detection of locally advanced breast cancer in the I-SPY TRIAL Hopeful	06-03-2009 06:34 AM by Hopeful	0	735
A study of lavender and tea tree oils on postmenopausal FSH levels and hot flash seve Hopeful	06-03-2009 07:26 PM by Laurel	1	1,161
Effect of simvastatin on the pharmacokinetics of anastrozole Hopeful	06-03-2009 06:38 AM by Hopeful	0	789
Evaluation of the effect of screening on the detection of good and poor prognosis bc Hopeful	06-04-2009 06:22 AM by Hopeful	0	841
Factors leading to the decision for contralateral prophylactic mastectomy Hopeful	06-04-2009 06:23 AM by Hopeful	0	873
Neuroprotective effect of SSRI among 781 cancer patients receiving chemotherapy Hopeful	06-04-2009 06:26 AM by Hopeful	0	890

Page 2 of 14

Last »

	New posts		Hot thread with new posts
	No new posts		Hot thread with no new posts
	Thread is closed

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is On Forum Rules

All times are GMT -7. The time now is 08:50 AM.